• Home
  • NEW DAY MEDICINE
  • 11 (85) 2025
  • 90 -11 (85) 2025 - Nazarov B.B. - ACQUIRED CERVICAL TUMORS IN WOMEN WITH INDICATIONS FOR DETERMINING THE STATUS OF IMMUNOGLOBULINS IN THE BLOOD SERUM

90 -11 (85) 2025 - Nazarov B.B. - ACQUIRED CERVICAL TUMORS IN WOMEN WITH INDICATIONS FOR DETERMINING THE STATUS OF IMMUNOGLOBULINS IN THE BLOOD SERUM

ACQUIRED CERVICAL TUMORS IN WOMEN WITH INDICATIONS FOR DETERMINING THE STATUS OF IMMUNOGLOBULINS IN THE BLOOD SERUM

Nazarov B.B. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Tumors of the cervix in women are characterized by a severe course, low therapeutic effect, often leading to death. It has been proven that one of the main risk factors for medical and socio-economic problems are diseases that have led to the formation of cervical tumors. It follows that it is much more important to prevent this tumor disease than to treat it, and to treat it without complications by diagnosing pre-existing cervical diseases. Many diagnostic methods are recommended for this, and it is important to keep them under constant monitoring. However, one of the biggest problems is their initial identification, since it is impossible for women to seek medical help if they do not consider themselves healthy and experience symptoms of pain and discomfort. In addition, the mentality of our people reflects this situation, and the problem of timely treatment is at the forefront.

Keywords. cases of acquired cervical tumors, the content of immunoglobulins in blood serum.

First page

530

Last page

536

For citation:Nazarov B.B. - ACQUIRED CERVICAL TUMORS IN WOMEN WITH INDICATIONS FOR DETERMINING THE STATUS OF IMMUNOGLOBULINS IN THE BLOOD SERUM//New Day in Medicine 11(85)2025 530-536 https://newdayworldmedicine.com/en/new_day_medicine/11-85-2025

List of References

  1. Абакумова Т.В., Мягдиева И.Р., Долгова Д.Р., Генинг С.О., Антонеева И.И., Генинг Т.П. IL-4 и его полиморфизм (IL4-589C/T) при цервикальной неоплазии // Медицинская иммунология. 2023;25(5):1129-1134.
  2. Белявская В.А., Чердынцева Н.В., Кжышковска Ю.Г., Литвяков Н.В. Микробиом, иммунная система и рак: три стороны одной медали // Сибирский онкологический журнал. 2022;21(6):131-144.
  3. Гизингер О.А. Иммуномодуляция в гинекологии. Мнение иммунолога и акушера-гинеколога. Вопросы практической кольпоскопии // Генитальные инфекции. 2022;2:18-23.
  4. Ихтиярова Г.А., Наврузова Н.О., Каримова Г.К. Современные диагностические методы для раннего выявления заболеваний шейки матки // Доктор ахборотномаси. 2019;4:78-80.
  5. Логинова О.П., Шевченко Н.И., Гасич Е.Л. Особенности локального иммунитета влагалища при ВПЧ-негативной дисплазии шейки матки // Новости медико-биологических наук. 2025;25(3):230-239.
  6. Мазитова М.И., Бикинеев М.С. Этапы развития цитологического скрининга рака шейки матки // РМЖ. Мать и дитя. 2019;2(4):322-326.
  7. Мамедов У.С., Мирахмедова С.С. Динамика иммунного статуса женщин при лечении вируса папилломы человека шейки матки // Вестник науки и образования. 2020;24(102)3:81-84.
  8. Петров Ю.А., Блесманович А.Е., Багновская А.Г. От фоновых процессов к раку шейки матки: причины, диагностика и профилактика // Главный врач Юга России. 2020;74(4):36-39.
  9. Семиглазов В.Ф. и др. Иммунология и иммунотерапия в комплексном лечении злокачественных опухолей // Медицинский совет. 2021;4:248-257.
  10. Mamedov U.S., Pulatova D.SH. The Results of Cancer Treatment of the Oral Cavity Tumors in The Republic of Uzbekistan // European Journal of Pharmaceutical and Medical Research. 2019;6(9):326-329.
  11. Oripova F.Sh., Ikhtiyarova G.A., Davlatov S.S. Pathomorphological characteristics of the vaginal mucosa in experimental nonspecific vaginitis and various methods of treatment // International Journal of Pharmaceutical Research. 2021;13(1):761-765.
  12. Smola S., Trimble C., Stern P.L. Human papillomavirus-driven immune deviation: challenge and novel opportunity for immunotherapy // Ther Adv Vaccines. 2017;5:69-82.
  13. Wang Y., Li G. PD-1/PD-L1 blockade in cervical cancer: current studies and perspectives // Front Med. 2019;13:438-450.
  14. Zhen S. et al. Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout // Cancer Gene Ther. 2019;27:168-178.

    file

    download